New Automated Immunosuppressive Drug Assays Improve Therapeutic Drug Monitoring for Transplant Patients For the first time, certain immunosuppressive drug (ISD) assays can now be performed automatically on cobas® modular platforms, allowing laboratories to consolidate testing for a wide range of transplant testing/monitoring assays onto a single platform. The new Roche automated assays for tacrolimus and cyclosporine will enhance therapeutic drug monitoring (TDM) of transplant recipients by ...
July 3, 2013 - PharmaceuticalOnline